Platelet‑rich plasma promotes the migration and invasion of synovial fibroblasts in patients with rheumatoid arthritis

Yan,Shanshan; Yang,Binzhou; Shang,Chen; Ma,Zhongshuang; Tang,Zizheng; Liu,Guiping; Shen,Weigan; Zhang,Yu

doi:10.3892/mmr.2016.5500

Platelet‑rich plasma promotes the migration and invasion of synovial fibroblasts in patients with rheumatoid arthritis

Authors:
- Shanshan Yan
- Binzhou Yang
- Chen Shang
- Zhongshuang Ma
- Zizheng Tang
- Guiping Liu
- Weigan Shen
- Yu Zhang
View Affiliations

Affiliations: School of Medicine, Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Rheumatology, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu 222000, P.R. China
Published online on: July 11, 2016 https://doi.org/10.3892/mmr.2016.5500
Pages: 2269-2275

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Platelet-rich plasma (PRP) is blood plasma that has been enriched with platelets, and the number of platelets is correlated with rheumatoid activity. PRP is a concentrated source of autologous platelets, and contains several different growth factors and cytokines, including platelet‑derived growth factor, transforming growth factor‑β and insulin‑like growth factor‑1, which stimulate healing of bone and soft tissue. Rheumatoid arthritis (RA) is characterized by synovial hyperplasia, cell activation, articular inflammation and invasion of the synovium into the adjacent bone and cartilage. The adhesion of fibroblast‑like synoviocytes (FLSs) onto the extracellular matrix (ECM), migration and invasion are important for the erosion and destruction of the articular cartilage of patients with RA. The aim of the present study was to investigate the effects of PRP on the adhesion, migration and invasion of RA‑FLSs. Scratch and Transwell migration assays determined that PRP at a concentration of 2 and 5% significantly enhanced the migration ability of RA‑FLSs. Treatment of RA‑FLSs with 2 and 5% PRP promoted the adhesion and invasion of the cells. Additionally, the immunofluorescence assay revealed that PRP induced a decrease in the number of centrally located stress fibers and led to an increase in the formation of filopodia and lamellipodia in the detectable leading edge protrusions in RA‑FLSs. In addition, reverse transcription‑quantitative polymerase chain reaction and western blot analysis determined that PRP upregulated the protein and mRNA expression levels of matrix metalloproteinase‑1 (MMP‑1). In conclusion, the promotion of RA‑FLS cell migration, invasion and adhesion on the ECM by PRP may be modulated through the upregulation of MMP‑1 expression and the induction of actin cytoskeletal reorganization.

View Figures

View References

1	Karouzakis E, Neidhart M, Gay RE and Gay S: Molecular and cellular basis of rheumatoid joint destruction. Immunol Lett. 106:8–13. 2006. View Article : Google Scholar : PubMed/NCBI
2	Müller-Ladner U, Pap T, Gay RE, Neidhart M and Gay S: Mechanisms of disease: The molecular and cellular basis of joint destruction in rheumatoid arthritis. Nat Clin Pract Rheumatol. 1:102–110. 2005. View Article : Google Scholar
3	Bartok B and Firestein GS: Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
4	Gravallese EM: Bone destruction in arthritis. Ann Rheum Dis. 61(Suppl 2): ii84–ii86. 2002. View Article : Google Scholar : PubMed/NCBI
5	Looney RJ: B cell-targeted therapy for rheumatoid arthritis: An update on the evidence. Drugs. 66:625–639. 2006. View Article : Google Scholar : PubMed/NCBI
6	Ma Y and Pope RM: The role of macrophages in rheumatoid arthritis. Curr Pharm Des. 11:569–580. 2005. View Article : Google Scholar : PubMed/NCBI
7	Skapenko A, Leipe J, Lipsky PE and Schulze-Koops H: The role of the T cell in autoimmune inflammation. Arthritis Res Ther. 7(Suppl 2): S4–S14. 2005. View Article : Google Scholar : PubMed/NCBI
8	Yasuda T: Cartilage destruction by matrix degradation products. Mod Rheumatol. 16:197–205. 2006. View Article : Google Scholar : PubMed/NCBI
9	Klareskog L, Catrina AI and Paget S: Rheumatoid arthritis. Lancet. 373:659–672. 2009. View Article : Google Scholar : PubMed/NCBI
10	Huber LC, Distler O, Tarner I, Gay RE, Gay S and Pap T: Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford). 45:669–675. 2006. View Article : Google Scholar
11	Lefèvre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, Korb A, Schnäker EM, Tarner IH, Robbins PD, et al: Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 15:1414–1420. 2009. View Article : Google Scholar : PubMed/NCBI
12	Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE and Huizinga TW: Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum. 52:1999–2002. 2005. View Article : Google Scholar : PubMed/NCBI
13	Karouzakis E, Gay RE, Gay S and Neidhart M: Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol. 5:266–272. 2009. View Article : Google Scholar : PubMed/NCBI
14	Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, Breedveld FC and Huizinga TW: Invasive properties of fibroblast-like synoviocytes: Correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis. 61:975–980. 2002. View Article : Google Scholar : PubMed/NCBI
15	Marx RE: Platelet-rich plasma (PRP): What is PRP and what is not PRP? Implant Dent. 10:225–228. 2001. View Article : Google Scholar
16	Wang F, Wang NS, Yan CG, Li JH and Tang LQ: The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol. 26:768–771. 2007. View Article : Google Scholar : PubMed/NCBI
17	Endresen GK: Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis. Rheumatol Int. 9:19–24. 1989. View Article : Google Scholar : PubMed/NCBI
18	Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, Massarotti EM, Remold-O'Donnell E, Farndale RW, Ware J and Lee DM: Platelets amplify inflammation in arthritis via collagen dependent microparticle production. Science. 327:580–583. 2010. View Article : Google Scholar : PubMed/NCBI
19	Han J, Meng HX, Tang JM, Li SL, Tang Y and Chen ZB: The effect of different platelet-rich plasma concentration on proliferation and differentiation of human periodontal ligament cells in vitro. Cell Prolif. 40:241–252. 2007. View Article : Google Scholar : PubMed/NCBI
20	Anitua E, Andia I, Ardanza B, Nurden P and Nurden AT: Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 91:4–15. 2004.
21	Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W and Nishihara T: Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg. 63:362–369. 2005. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
23	Shin MK, Lee JW, Kim YI, Kim YO, Seok H and Kim NI: The effects of platelet-rich clot releasate on the expression of MMP-1 and type I collagen in human adult dermal fibroblasts: PRP is a stronger MMP-1 stimulator. Mol Biol Rep. 41:3–8. 2014. View Article : Google Scholar
24	Kakudo N, Morimoto N, Kushida S, Ogawa T and Kusumoto K: Platelet-rich releasate promotes angiogenesis in vitro and in vivo. Med Mol Morphol. 47:83–89. 2014. View Article : Google Scholar
25	Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ and Kusumoto K: Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 122:1352–1360. 2008. View Article : Google Scholar : PubMed/NCBI
26	Kakudo N, Kushida S, Minakata T, Suzuki K and Kusumoto K: Platelet-rich plasma promotes epithelialization and angiogenesis in a split thickness skin graft donor site. Med Mol Morphol. 44:233–236. 2011. View Article : Google Scholar : PubMed/NCBI
27	Volin MV, Huynh N, Klosowska K, Chong KK and Woods JM: Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Arthritis Rheum. 56:2512–2522. 2007. View Article : Google Scholar : PubMed/NCBI
28	Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E and Goldring SR: Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43:250–258. 2000. View Article : Google Scholar : PubMed/NCBI
29	Akakura S and Gelman IH: Pivotal role of AKAP12 in the regulation of cellular adhesion dynamics: Control of cytoskeletal architecture, cell migration, and mitogenic signaling. J Signal Transduct. 2012:5291792012. View Article : Google Scholar : PubMed/NCBI
30	Murray GI, Duncan ME, O'Neil P, Melvin WT and Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med. 2:461–462. 1996. View Article : Google Scholar : PubMed/NCBI
31	McGowan PM and Duffy MJ: Matrix metalloproteinase expression and outcome in patients with breast cancer: Analysis of a published database. Ann Oncol. 19:1566–1572. 2008. View Article : Google Scholar : PubMed/NCBI
32	Lu X, Wang Q, Hu G, Van Poznak C, Fleisher M, Reiss M, Massagué J and Kang Y: ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis. Genes Dev. 23:1882–1894. 2009. View Article : Google Scholar : PubMed/NCBI
33	Pei D: Matrix metalloproteinases target protease-activated receptors on the tumor cell surface. Cancer Cell. 7:207–208. 2005. View Article : Google Scholar : PubMed/NCBI